Quick Answer
Sight Sciences, Inc. reported Total Revenue of $77.36 million for fiscal year 2025.
Sight Sciences, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $77.36M -3.1% |
$79.87M -1.5% |
$81.06M +13.6% |
$71.33M +45.7% |
$48.96M +77.1% |
$27.64M |
| Revenue (ASC 606) | $77.36M -3.1% |
$79.87M -1.5% |
$81.06M +13.6% |
$71.33M +45.7% |
$48.96M +77.1% |
$27.64M |
| Net Income | -$38.43M +25.4% |
-$51.51M +7.3% |
-$55.55M +35.6% |
-$86.24M -37.0% |
-$62.96M -81.5% |
-$34.69M |
| Diluted EPS | -$0.74 +28.2% |
-$1.03 +9.6% |
-$1.14 +36.7% |
-$1.80 +23.7% |
-$2.36 | — |
| Total Assets | $115.30M -19.3% |
$142.84M -14.3% |
$166.65M -21.8% |
$213.07M -24.0% |
$280.19M +284.8% |
$72.81M |
| Cash and Equivalents | $91.97M -23.6% |
$120.36M -12.9% |
$138.13M -25.3% |
$185.00M -29.0% |
$260.69M +323.8% |
$61.51M |
| Long-Term Debt | $40.30M +2.4% |
$39.36M +24.1% |
$31.71M -4.8% |
$33.31M +2.0% |
$32.66M +2.2% |
$31.95M |
| Stockholders Equity | $63.94M -26.9% |
$87.52M -27.2% |
$120.22M -24.9% |
$160.08M -31.0% |
$232.11M +361.2% |
-$88.85M -62.5% |
| R&D Expense | $14.61M -18.8% |
$17.99M +2.5% |
$17.56M -23.2% |
$22.86M +46.2% |
$15.63M +76.2% |
$8.87M |
| Operating Income | -$37.10M +26.6% |
-$50.53M +11.8% |
-$57.27M +31.8% |
-$83.95M -63.1% |
-$51.48M -59.9% |
-$32.19M |
| Gross Profit | $66.67M -2.4% |
$68.28M -1.3% |
$69.17M +17.3% |
$58.97M +46.2% |
$40.35M +118.9% |
$18.43M |
| Shares Outstanding | 53.49M +5.0% |
50.94M +3.7% |
49.13M +1.7% |
48.30M +1.7% |
47.50M +399.6% |
9.51M |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $19.91M | -1.2% | +1.7% |
| Revenue (ASC 606) | September 30, 2025 | $19.91M | -1.2% | +1.7% |
| Net Income | September 30, 2025 | -$8.17M | +26.2% | +31.6% |
| Diluted EPS | September 30, 2025 | -$0.16 | +27.3% | +30.4% |
| Total Assets | September 30, 2025 | $116.26M | -19.0% | -4.7% |
| Cash and Equivalents | September 30, 2025 | $92.37M | -22.1% | -9.0% |
| Long-Term Debt | September 30, 2025 | $40.07M | +17.3% | +0.6% |
| Stockholders Equity | September 30, 2025 | $64.29M | -32.3% | -8.2% |
| R&D Expense | September 30, 2025 | $3.35M | -29.4% | -23.6% |
| Operating Income | September 30, 2025 | -$7.91M | +29.6% | +32.2% |
| Gross Profit | September 30, 2025 | $17.20M | +1.7% | +3.7% |
| Shares Outstanding | September 30, 2025 | 52.47M | +4.1% | +0.8% |
- Sight Sciences, Inc. reported Total Revenue of $77.36 million for fiscal year 2025.
- Sight Sciences, Inc. showed a decrease of -3.1% in Total Revenue compared to the prior fiscal year.
- Sight Sciences, Inc. reported Revenue (ASC 606) of $77.36 million for fiscal year 2025.
- Sight Sciences, Inc. showed a decrease of -3.1% in Revenue (ASC 606) compared to the prior fiscal year.
- Sight Sciences, Inc. reported Net Income of -$38.43 million for fiscal year 2025.
- Sight Sciences, Inc. showed an increase of +25.4% in Net Income compared to the prior fiscal year.
- Sight Sciences, Inc. reported Diluted EPS of $0.74 per share (loss) for fiscal year 2025.
- Sight Sciences, Inc. showed an increase of +28.2% in Diluted EPS compared to the prior fiscal year.
- Sight Sciences, Inc. reported Total Assets of $115.30 million for fiscal year 2025.
- Sight Sciences, Inc. showed a decrease of -19.3% in Total Assets compared to the prior fiscal year.
- Sight Sciences, Inc. reported Cash and Equivalents of $91.97 million for fiscal year 2025.
- Sight Sciences, Inc. showed a decrease of -23.6% in Cash and Equivalents compared to the prior fiscal year.
- Sight Sciences, Inc. reported Long-Term Debt of $40.30 million for fiscal year 2025.
- Sight Sciences, Inc. showed an increase of +2.4% in Long-Term Debt compared to the prior fiscal year.
- Sight Sciences, Inc. reported Stockholders Equity of $63.94 million for fiscal year 2025.
- Sight Sciences, Inc. showed a decrease of -26.9% in Stockholders Equity compared to the prior fiscal year.
- Sight Sciences, Inc. reported R&D Expense of $14.61 million for fiscal year 2025.
- Sight Sciences, Inc. showed a decrease of -18.8% in R&D Expense compared to the prior fiscal year.
- Sight Sciences, Inc. reported Operating Income of -$37.10 million for fiscal year 2025.
- Sight Sciences, Inc. showed an increase of +26.6% in Operating Income compared to the prior fiscal year.
- Sight Sciences, Inc. reported Gross Profit of $66.67 million for fiscal year 2025.
- Sight Sciences, Inc. showed a decrease of -2.4% in Gross Profit compared to the prior fiscal year.
- Sight Sciences, Inc. reported Shares Outstanding of 53.49 million shares for fiscal year 2025.
- Sight Sciences, Inc. showed an increase of +5.0% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: